Abbott | ABT - Current Assets

Stock Price
109.02
Daily Change
-0.39 -0.36%
Monthly
-13.78%
Yearly
-15.55%
Q1 Forecast
105.93

Abbott reported $24.84B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Agilent USD 4.59B 341M Sep/2025
AtriCure USD 301.11M 29.85M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
Boston Scientific USD 8.04B 914M Sep/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Dexcom USD 5.22B 189.3M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Insulet USD 1.86B 420.3M Sep/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 54.61B 113M Sep/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 23.22B 591M Jun/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Solventum Corp USD 4.41B 1.2B Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 616.94M 2.13M Sep/2025
Teleflex USD 1.99B 262.12M Sep/2025
Terumo JPY 744.08B 26B Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Zimmer Biomet Holdings USD 5.83B 781M Sep/2025